October 13, 2003
Banyu Pharmaceutical presented the results of a subanalysis of diabetic patients from the large clinical study on simvastatin, the Heart Protection Study (HPS), at a meeting of the Japan Atherosclerosis Society in Kyoto held from September 29. The presentation was...read more